Skip to main content
Clinical Trials/NCT03342820
NCT03342820CompletedNot Applicable

Impact of Muscular Fatigability on Spastic Co-contractions Between the Quadriceps and Hamstrings in Stroke Patients

University Hospital, Lille1 site in 1 country30 target enrollmentStarted: January 19, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Cocontraction Index (CCI) between the rectus femoris and the semitendinosus

Study Overview

Brief Summary

This study evaluates the effects of an isokinetic fatigue protocol of the quadriceps on the amount of co-contractions of this last with the hamstrings during a maximal isometric flexion movement in hemiparetic stroke patients.

The effect of such a protocol on gait parameters and spasticity of the quadriceps will be evaluated also.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age between 18 and 80y
  • Hemiparesis after a first-ever stroke > 3 months
  • Spasticity of the quadriceps muscle
  • Quadriceps strength at least at 3/5 (MRC testing)
  • Subject able to walk at least 2min without rest
  • Informed consent
  • Social security affiliation

Exclusion Criteria

  • Severe comprehension troubles (language, cognitive or psychiatric disorders)
  • History of previous stroke, locomotor or other neurological disorders
  • Locomotor troubles affecting the paretic arm
  • Contraindication to efforts : cardiac insufficiency, severe aortic valvular stenosis, recent heart failure, non treated high blood pressure, severe peripheral arterial disease
  • Pregnancy or breastfeeding
  • Adult subject to guardianship

Outcomes

Primary Outcomes

Cocontraction Index (CCI) between the rectus femoris and the semitendinosus

Time Frame: one day

ratio of the RMS of a the rectus femoris when acting as antagonist to the effort intended (knee flexion) to the RMS of the same muscle when acting as an agonist during a reciprocal maximal isometric knee flexion effort (500 ms around the peak of rectified EMG

Secondary Outcomes

  • 10 metre walk test (10MWT)(one day)
  • Isometric peak knee flexion torque(one day)
  • Cocontraction Index (CCI) between the other parts of the quadriceps and the semitendinosus muscle(one day)
  • Spasticity of the quadriceps(one day)
  • 2 minute walk test (2MWT)(one day)
  • Agonist Recruitment Index of the semitendinosus(one day)
  • Isometric peak knee extension torque(one day)
  • perceived exertion at the end of the 2MWT (Borg Scale 6-20)(one day)
  • spatio-temporal gait parameters at comfortable speed(one day)

Investigators

Sponsor
University Hospital, Lille
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials